Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. uri icon

authors

  • Ringman, John M
  • Liana Apostolova, MD, MSc, FAAN
  • Porter, Verna
  • Vanek, Zeba
  • Marshall, Gad A
  • Hellemann, Gerhard
  • Sugar, Catherine
  • Masterman, Donna L
  • Montine, Thomas J
  • Cummings, Jeffrey L
  • Cole, Greg M
  • Frautschy, Sally A
  • Teng, Edmond
  • Begum, Aynun N
  • Bardens, Jenny
  • Beigi, Maryam
  • Gylys, Karen H
  • Badmaev, Vladimir
  • Heath, Dennis D

publication date

  • January 1, 2012